Avanos Medical (NYSE:AVNS) Sees Large Volume Increase – Here’s What Happened

Avanos Medical, Inc. (NYSE:AVNS) shares saw an uptick in trading volume on Friday . 706,848 shares traded hands during mid-day trading, an increase of 16% from the previous session’s volume of 609,186 shares.The stock last traded at $15.34 and had previously closed at $15.40.

Analyst Ratings Changes

Separately, StockNews.com lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Stock Performance

The stock has a market cap of $700.84 million, a price-to-earnings ratio of 44.85 and a beta of 0.99. The company’s fifty day simple moving average is $17.91 and its two-hundred day simple moving average is $20.93. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Institutional Investors Weigh In On Avanos Medical

A number of institutional investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company grew its position in Avanos Medical by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock valued at $341,000 after buying an additional 590 shares during the period. KBC Group NV increased its stake in shares of Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares during the last quarter. New York State Teachers Retirement System raised its holdings in shares of Avanos Medical by 2.0% in the 3rd quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,388 shares during the period. Quarry LP purchased a new position in Avanos Medical in the third quarter valued at approximately $42,000. Finally, Foundry Partners LLC grew its holdings in Avanos Medical by 1.1% during the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,800 shares during the period. 95.17% of the stock is owned by institutional investors.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.